HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction - Pharmacological approaches

被引：24

作者：

Adams, KF ^{[1
]}

Baughman, KL ^{[1
]}

Dec, WG ^{[1
]}

Elkayam, U ^{[1
]}

Forker, AD ^{[1
]}

Gheorghiade, M ^{[1
]}

Hermann, D ^{[1
]}

Konstam, MA ^{[1
]}

Liu, P ^{[1
]}

Massie, BM ^{[1
]}

Patterson, JH ^{[1
]}

Silver, MA ^{[1
]}

Stevenson, LW ^{[1
]}

Feldman, AM ^{[1
]}

Cohn, JN ^{[1
]}

Francis, GS ^{[1
]}

Greenberg, B ^{[1
]}

Konstam, MA ^{[1
]}

Leier, C ^{[1
]}

Lorell, BH ^{[1
]}

Packer, M ^{[1
]}

Pitt, B ^{[1
]}

Silver, MA ^{[1
]}

Sonnenblick, E ^{[1
]}

Strobeck, J ^{[1
]}

Walsh, R ^{[1
]}

Yusuf, S ^{[1
]}

机构：

[1] HFSA, Minneapolis, MN 55455 USA

来源：

PHARMACOTHERAPY | 2000年 / 20卷 / 05期

关键词：

D O I：

10.1592/phco.20.6.495.35164

中图分类号：

R9 [药学];

学科分类号：

1007 [药学];

摘要：

引用

收藏

页码：495 / 522

页数：28

相关论文

共 129 条

[1]

Patients with mild heart failure worsen during withdrawal from digoxin therapy [J].

Adams, KF ;

Gheorghiade, M ;

Uretsky, BF ;

Young, JB ;

Ahmed, S ;

Tomasko, L ;

Packer, M .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 30 (01) :42-48

[2]

Clinical definition and epidemiology of advanced heart failure [J].

Adams, KF ;

Zannad, F .

AMERICAN HEART JOURNAL, 1998, 135 (06) :S204-S215

[3]

Adams Kirkwood F. Jr., 1999, Journal of the American College of Cardiology, V33, p185A

[4]

Antiplatelet agents and survival: A cohort analysis from the studies of left ventricular dysfunction (SOLVD) trial [J].

Al-Khadra, AS ;

Salem, DN ;

Rand, WM ;

Udelson, JE ;

Smith, JJ ;

Konstam, MA .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) :419-425

[5]

Warfarin anticoagulation and survival: A cohort analysis from the studies of left ventricular dysfunction [J].

Al-Khadra, AS ;

Salem, DN ;

Rand, WM ;

Udelson, JE ;

Smith, JJ ;

Konstam, MA .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (04) :749-753

[6]

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS [J].

ALTMAN, R ;

CARRERAS, L ;

DIAZ, R ;

FIGUEROA, E ;

PAOLASSO, E ;

PARODI, JC ;

CADE, JF ;

DONNAN, G ;

EADIE, MJ ;

GAVAGHAN, TP ;

OSULLIVAN, EF ;

PARKIN, D ;

RENNY, JTG ;

SILAGY, C ;

VINAZZER, H ;

ZEKERT, F ;

ADRIAENSEN, H ;

BERTRANDHARDY, JM ;

BRAN, M ;

DAVID, JL ;

DRICOT, J ;

LAVENNEPARDONGE, E ;

LIMET, R ;

LOWENTHAL, A ;

MORIAU, M ;

SCHAPIRA, S ;

SMETS, P ;

SYMOENS, J ;

VERHAEGHE, R ;

VERSTRAETE, M ;

ATALLAH, A ;

BARNETT, H ;

BATISTA, R ;

BLAKELY, J ;

CAIRNS, JA ;

COTE, R ;

CROUCH, J ;

EVANS, G ;

FINDLAY, JM ;

GENT, M ;

LANGLOIS, Y ;

LECLERC, J ;

NORRIS, J ;

PINEO, GF ;

POWERS, PJ ;

ROBERTS, R ;

SCHWARTZ, L ;

SICURELLA, J ;

TAYLOR, W ;

THEROUX, P .

BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921) :81-100

[7]

*AM HEART ASS, 1998, HEART STROK STAT UPD

[8]

[Anonymous], 1988, LANCET, V2, P349

[9]

[Anonymous], 1988, JAMA, V259, P539

[10]

Aretz H T, 1987, Am J Cardiovasc Pathol, V1, P3

← 1 2 3 4 5 6 7 8 9 10 →